Abstract
Outcome measures in major depressive disorder have traditionally focused on characteristic symptoms included in the DSM-51 definition of major depressive disorder (MDD): depressed mood, lack of interest or pleasure in activities, fatigue, guilt, and change in weight/appetite. Addressing these symptoms is clearly a treatment priority, especially in the acute stages of the treatment process. However, patients express that, beyond symptom relief, they have additional goals: restoration of functioning and of the feeling that one can participate in, and engage with, their own life. Life engagement encompasses aspects of life experience relating to cognition (including cognition colored by emotion), vitality, motivation and reward, and the ability to feel pleasure.2 In a recent roundtable meeting, a panel of 5 experts discussed life engagement and its relationship to symptoms and functioning in patients with major depressive disorder and schizophrenia. This Academic Highlights, part 3 in a series, summarizes the experts’ discussion of how life engagement can be integrated into patient-centered discussions of treatment goals, as well as how it can inform treatment selection for those with MDD.
Cite
CITATION STYLE
Correll, C. U., Ismail, Z., McIntyre, R. S., Rafeyan, R., & Thase, M. E. (2022). Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder. Journal of Clinical Psychiatry, 83(5). https://doi.org/10.4088/JCP.LU21112AH3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.